Sintx Technologies, Inc.

NASDAQ (USD): Sintx Technologies, Inc. (SINT)

Last Price


Today's Change

-0.34 (5.90%)

Day's Change

5.30 - 6.09

Trading Volume



Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare


CEO:  Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D. Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D.

Full Time Employees:  43 43

IPO Date:  2014-02-13 2014-02-13

CIK:  0001269026 0001269026

ISIN:  US8293926049 US8293926049

CUSIP:  829392307 829392307

Beta:  1.34 1.34

Last Dividend:  0.00 0.00

Dcf Diff:  0.07 0.07

Dcf:  -0.02 -0.02


Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.


1885 West 2100 South,
Salt Lake City, UT 84119, US

801 839 3500

Be the first to like this. Showing 0 of 0 comments

Post a Comment